9 nov 2021
CPhI Worldwide 2021
PolyPeptide Group

PolyPeptide Group

Exhibitor at CPhI Worldwide 2021 stand stand 9E68

About us

The PolyPeptide Group is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products. Dating back to 1952, PolyPeptide today manufactures around one half of all currently approved peptide drug substances with a global footprint of six GMP-certified facilities in Europe, the U.S. and India. As a multinational company with more than 900 employees, its diversity brings breadth, depth of knowledge and experience to the group. PolyPeptide has grown organically and by selective acquisition of existing expertise, culminating in its position today as a leader in outsourced peptide manufacturing.

Specs about this supplier

Sales markets Middle East Region (e.g. UAE); Oceania; North America (USA, Canada); Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)
Affiliated categories: API Contract Manufacturing |Custom Manufacturing |Functional Food And Nutraceutical Ingredients More

Products featured at CPhI Worldwide 2021

PolyPeptide Group

Event information

CPhI Worldwide 2021

9-11 November 2021 Fiera Milano, Milan, Italy Visit us at stand 9E68